Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
Clinical trial NCT02466568 · WITHDRAWN
Trial details
- NCT number
- NCT02466568
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2019-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.